Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Size
420Catalog no#
RPA139Mu01Price
2670 EURIsoelectric Point
7.7
Accurate Molecular Mass(KD)
37kDa
Tissue
tumor
Predicted Molecular Mass(KD)
35.9kDa
Purity
≥ 92%
Protein length
Met40~Asn291
Group
recombinants
Traits
Freeze-dried powder
Organism species
Mus musculus (Mouse)
Expression System
Prokaryotic expression
Source
Prokaryotic expression
Research Area
Apoptosis;Tumor immunity;
Additional source
Recombinants or rec. proteins
Tag
two N-terminal Tags, His-tag and T7-tag
Application
Positive Control; Immunogen; SDS-PAGE; WB.
Item Name
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
Buffer Formulation
20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
Alternative Names
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
Description
This 1 is suited for programmed cell-death studies.Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.FAS ligand and other ligands are binding to the receptor for signaling pathways for example in apoptosis or JNK signaling. Receptor agonists are often tested for drug development.